Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Specific inhibitory effects of the alkylammonium derivative 6-methyluracil on acetylcholinesterase of smooth and striated muscles in rats.

× No keyword cloud information.

10 in total

1. Different sensitivity of miniature endplate currents in rat external and internal intercostal muscles to the acetylcholinesterase inhibitor C-547 as compared with diaphragm and extensor digitorum longus.

Authors: K Petrov; I Kovyazina; V Zobov; E Bukharaeva; E E Nikolsky; F Vyskocil
Journal: Physiol Res Date: 2009 Impact factor: 1.881

Review 2. Monitoring of neuromuscular function.

Authors: H H Ali; J J Savarese
Journal: Anesthesiology Date: 1976-08 Impact factor: 7.892

3. Mechanisms of cardiac muscle insensitivity to a novel acetylcholinesterase inhibitor C-547.

Authors: Denis V Abramochkin; Konstantin A Petrov; Vladimir V Zobov; Lilia O Yagodina; Eugen E Nikolsky; Leonid V Rosenshtraukh
Journal: J Cardiovasc Pharmacol Date: 2009-02 Impact factor: 3.105

4. Neostigmine for the treatment of acute colonic pseudo-obstruction (ACPO) in pediatric hematologic malignancies.

Authors: Jae-Wook Lee; Kyong-Won Bang; Pil-Sang Jang; Nak-Gyun Chung; Bin Cho; Dae-Chul Jeong; Hack-Ki Kim; Soo-Ah Im; Gye-Yeon Lim
Journal: Korean J Hematol Date: 2010-03-31

Review 5. Clinical limitations of acetylcholinesterase antagonists.

Authors: James E Caldwell
Journal: J Crit Care Date: 2009-01-17 Impact factor: 3.425

Review 6. The origin of the molecular diversity and functional anchoring of cholinesterases.

Authors: Jean Massoulié
Journal: Neurosignals Date: 2002 May-Jun

7. Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.

Authors: P Maddison; B Lang; K Mills; J Newsom-Davis
Journal: J Neurol Neurosurg Psychiatry Date: 2001-02 Impact factor: 10.154

Review 8. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation.

Authors: Talma Brenner; Eran Nizri; Michal Irony-Tur-Sinai; Yasmine Hamra-Amitay; Itzhak Wirguin
Journal: J Neuroimmunol Date: 2008-08-05 Impact factor: 3.478

9. How myasthenia gravis alters the safety factor for neuromuscular transmission.

Authors: Robert L Ruff; Vanda A Lennon
Journal: J Neuroimmunol Date: 2008-07-15 Impact factor: 3.478

10. Promoter elements and transcriptional regulation of the acetylcholinesterase gene.

Authors: T J Ekström; W M Klump; D Getman; M Karin; P Taylor
Journal: DNA Cell Biol Date: 1993 Jan-Feb Impact factor: 3.311

10 in total